Hematuria in a patient with class IV lupus nephritis

被引:2
|
作者
Mittal, B. V.
Pendse, S.
Rennke, H. G.
Singh, A. K.
机构
[1] Brigham & Womens Hosp, Div Renal, Boston, MA 02120 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02120 USA
关键词
D O I
10.1038/sj.ki.5001730
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 49-year-old Hispanic female with a past medical history notable for systemic lupus erythematosus (SLE) and biopsy proven lupus nephritis, hypertension, and peptic ulcer disease was referred for evaluation of hematuria. The patient also reported recent h/o arthralgias, some worsening of her existing malar and discoid rashes, and intermittent fevers. She denied any history of gross hematuria, dyspnea, chest pain, abdominal pain, fatigue, oral ulcers, Raynaud's phenomenon, or edema. The patient was seen by her nephrologist and found to have 4+ protein and 2+ blood on urinalysis with urine sediment revealing moderate dysmorphic red cells and no casts. Her first kidney biopsy revealed diffuse proliferative lupus nephritis World Health Organization class IV. At this time, the patient had undergone treatment with monthly cyclophosphamide infusions along with steroids for 6 months. Her renal function revealed a creatinine clearance of 75 ml/min. Urinalysis revealed only few red blood cells with no casts, with resolution of her proteinuria. The frequency of cyclophosphamide pulses was decreased to every 3 months for the next 12 months, which was the dose at the patient's current presentation. Her medications included cyclophosphamide 0.85 g/m(2) every 3 months, prednisone 15 mg p.o. q.d., plaquenil 200 mg p.o. b.i.d., lisinopril 40 mg p.o. q.d., nifedipine XL 60 mg p.o. q.d., and calcium/multivitamin supplements. Her family history was negative for hematuria, proteinuria, or any other known renal disease. The patient was originally from El Salvador and had been in the United States for 11 years. She denied tobacco consumption and drank alcohol occasionally. Physical examination revealed a middle-aged female with a Cushingoid appearance. Her weight was stable at 162 lbs. Her blood pressure was 130/70 mmHg; she was afebrile. Skin examination revealed increased erythematous lesions in a malar distribution, along with a circular, erythematous, maculopapular rash throughout the proximal regions of her upper extremities and the upper front and back of her thorax in a shawl type of pattern. Musculoskeletal examination revealed no evidence for active synovitis. Lungs were clear to auscultation and her abdomen was benign. Her heart examination revealed a regular rate and rhythm with an I/VI systolic ejection murmur at the left sternal border, with no rubs or gallop. Extremities revealed trace pedal edema bilaterally. Laboratory values revealed a blood urea nitrogen and creatinine of 23 and 0.7 mg/dl, respectively; white blood cells 5.87; hemoglobin 11.0 g/dl; hematocrit 33.9; platelets 298,000; electronic spin resonance 81; double-stranded DNA 475 IU (Normal -0-25 IU); C3 52(Normal - 90-180 mg/dl); C4 16 (Normal - 10-40mg/dl), and CH50 of 62 (Normal - 150-250U/ml). Twenty-four hours protein collection revealed 1.075 g of proteinuria. Owing to persistent activity of her sediment as well as abnormal serologic tests (Table 1), the frequency of the cyclophosphamide infusions were increased from every 3 months to every month, and a repeat biopsy was performed in December of 1998.
引用
收藏
页码:1182 / 1186
页数:5
相关论文
共 50 条
  • [1] Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis
    Sawsan J. Hayat
    Sukhbir S. Uppal
    M. R. Narayanan Nampoory
    Kaivilayil V. Johny
    Ramkumar Gupta
    Mohammed Al-Oun
    [J]. Clinical Rheumatology, 2007, 26 : 973 - 975
  • [2] Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis
    Hayat, Sawsan J.
    Uppal, Sukhbir S.
    Nampoory, M. R. Narayanan
    Johny, Kaivilayil V.
    Gupta, Ramkumar
    Al-Oun, Mohammed
    [J]. CLINICAL RHEUMATOLOGY, 2007, 26 (06) : 973 - 975
  • [3] Proteomic analysis of Class IV lupus nephritis
    Alaiya, Ayodele
    Assad, Lina
    Alkhafaji, Dania
    Shinwari, Zakia
    Almana, Hadeel
    Shoukri, Mohamed
    Alkorbi, Lutfi
    Ibrahim, Hossamaldin Galal
    Abdelsalam, Mohamed Said
    Skolnik, Edward
    Adra, Chaker
    Albaqumi, Mamdouh
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (01) : 62 - 70
  • [4] MECHANISM OF HEMATURIA IN LUPUS NEPHRITIS
    MAKINO, H
    KAWASAKI, H
    MURAKAMI, K
    HIRONAKA, K
    AMANO, T
    OTA, Z
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (11) : 934 - 936
  • [5] Active WHO class IV lupus nephritis in a patient treated with etanercept for a psoriasic arthritis
    Sacquepee, Mathieu
    Rouleau, Vincent
    Cantin, Jean-Francois
    Quirin, Nicolas
    Doussy, Yves
    Valery, Jean-Claude
    Picu, Cristina
    Tivollier, Jean-Michel
    [J]. NEPHROLOGIE & THERAPEUTIQUE, 2010, 6 (06): : 537 - 540
  • [6] Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus
    Alkhatib, Momin H.
    Kant, Sam
    Menez, Steven
    Lakhani, Laila
    Sperati, Christopher John
    Fine, Derek M.
    Arend, Lois J.
    Atta, Mohamed G.
    [J]. JOURNAL OF NEPHROLOGY, 2021, 34 (06) : 1907 - 1913
  • [7] Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus
    Momin H. Alkhatib
    Sam Kant
    Steven Menez
    Laila Lakhani
    Christopher John Sperati
    Derek M. Fine
    Lois J. Arend
    Mohamed G. Atta
    [J]. Journal of Nephrology, 2021, 34 : 1907 - 1913
  • [8] Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
    Nawata, Takashi
    Kubo, Makoto
    Fujii, Shohei
    Shiragami, Kosaku
    Ikegami, Tadayoshi
    Kobayashi, Shigeki
    Hisano, Satoshi
    Yano, Masafumi
    [J]. INTERNAL MEDICINE, 2018, 57 (14) : 2067 - 2070
  • [9] Mycophenolate mofetil therapy in resistant class IV lupus nephritis
    Grcevska, L
    Polenakovic, M
    Dzikova, S
    Milovanceva-Popovska, M
    [J]. ALLERGY, 2002, 57 : 168 - 168
  • [10] CLINICAL STATUS AND GENE EXPRESSION IN CLASS IV LUPUS NEPHRITIS
    Mas, L. A.
    Saurit, V.
    Palomino, E.
    De la Fuente, J. L.
    Angelina, M.
    Alejandro, A.
    Alvarellos, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1212 - 1212